We seek to bridge the gap between spatial transcriptomics (ST), liver zonation and metabolic organization, and AEG-1 palmitoylation to further elucidate the molecular mechanisms underlying MASH and HCC pathogenesis. This evidence concerns the gene MTDH and hepatocellular carcinoma.